Brought to you by 
Schering-Plough licenses rights to Sepracor patents
13 Jul 1999
Executive Summary
Schering-Plough licensed exclusive rights to patents owned by Sepracor (chiral drugs) covering descarboethoxyloratainde (DCL), an active metabolite of SP's loratadine, the active ingredient in its successful antihistamine Claritin.
Deal Industry
- Biotechnology
-
Pharmaceuticals
- Chiral Chemistry
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com